Table 2.

Cell viability (resazurin assay) after exposure to FR

Conc. (µM)	BDE-47	TPHP	IPP	IDDP	TMPP
DIV14 (% of control)
Control	100 ± 6.9	100 ± 5.5	100 ± 6.3	100 ± 6.9	100 ± 6.9
0.1	97.7 ± 12.7	100.0 ± 8.9	104.6 ± 8.4	106.7 ± 10.6	89.9 ± 10.1
1	93.6 ± 17.4	92.2 ± 9.5	103.8 ± 8.5	108.2 ± 9.4	100.2 ± 10.9
5	93.6 ± 12.7	94.4 ± 18.7	100.7 ± 17.6	94.4 ± 14.3	101.1 ± 12.8
10	84.5 ± 8.8*	96.1 ± 19.2	92.9 ± 11.5	82.2 ± 7.6*	87.2 ± 18.8
20	76.0 ± 7.8*	77.5 ± 13.9*		75.3 ± 0.6*	81.7 ± 7.5
DIV21 (% of control)
Control	100 ± 12.3	100 ± 11.2	100 ± 11.5	100 ± 12.3	100 ± 12.3
0.1	89.2 ± 8.9	91.6 ± 13.1	91.2 ± 8.7	95.2 ± 10.0	94.1 ± 12.1
1	87.8 ± 12.5	87.9 ± 13.1	90.6 ± 10.9	94.7 ± 12.7	88.1 ± 14.0
5	84.4 ± 13.9*	77.9 ± 18.9*	78.2 ± 11.5*	72.1 ± 11.8*	65.6 ± 6.5*
10	80.0 ± 14.1*	64.4 ± 22.4*	54.5 ± 8.8*	61.7 ± 6.6*	56.8 ± 10.1*
20	39.3 ± 7.5*	23.3 ± 13.3*		59.0 ± 6.3*	56.0 ± 8.2*

Data expressed as mean ± SD. Statistical significance is indcated as follow *p < 0.05 (treated vs. control), using one-way ANOVA, Dunnett’s Multiple Comparison Test. followed by Dunnett’s multiple comparison post hoc test including correction for multiple testing. Post hoc test was only performed vs. controls